Mustang Bio Statistics Share Statistics Mustang Bio has 7.24M
shares outstanding. The number of shares has increased by 0.26%
in one year.
Shares Outstanding 7.24M Shares Change (YoY) 0.26% Shares Change (QoQ) 0.05% Owned by Institutions (%) 1.07% Shares Floating 6.03M Failed to Deliver (FTD) Shares 4,785 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 177.45K, so 2.45% of the outstanding
shares have been sold short.
Short Interest 177.45K Short % of Shares Out 2.45% Short % of Float 2.78% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -3.44 and the forward
PE ratio is -0.02.
Mustang Bio's PEG ratio is
0.06.
PE Ratio -3.44 Forward PE -0.02 PS Ratio 0 Forward PS 1 PB Ratio -14 P/FCF Ratio -4.75 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Mustang Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.68,
with a Debt / Equity ratio of -0.23.
Current Ratio 0.68 Quick Ratio 0.68 Debt / Equity -0.23 Debt / EBITDA -0.05 Debt / FCF -0.08 Interest Coverage 3249
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.63M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -89.63% in the
last 52 weeks. The beta is 2.23, so Mustang Bio's
price volatility has been higher than the market average.
Beta 2.23 52-Week Price Change -89.63% 50-Day Moving Average 1.8 200-Day Moving Average 3.48 Relative Strength Index (RSI) 41.08 Average Volume (20 Days) 5,841,830
Income Statement
Revenue n/a Gross Profit -823K Operating Income -16.25M Net Income -15.75M EBITDA -16.25M EBIT -15.76M Earnings Per Share (EPS) -2.57
Full Income Statement Balance Sheet The company has 6.84M in cash and 878K in
debt, giving a net cash position of 5.96M.
Cash & Cash Equivalents 6.84M Total Debt 878K Net Cash 5.96M Retained Earnings -396.72M Total Assets 13.05M Working Capital 3.04M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -11.41M
and capital expenditures 0, giving a free cash flow of -11.41M.
Operating Cash Flow -11.41M Capital Expenditures n/a Free Cash Flow -11.41M FCF Per Share -1.86
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields MBIO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for MBIO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 16, 2025. It was a
backward
split with a ratio of 1:50.
Last Split Date Jan 16, 2025 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -42.76 Piotroski F-Score 2
